Presenter

Kaylin Carey is a doctoral candidate at Morehouse School of Medicine specializing in cancer biology, with a focus on high-grade serous ovarian cancer. Her research integrates real-world data with RNA sequencing analysis to characterize mRNA subtypes that significantly impact clinical outcomes. Kaylin has co-authored publications in prestigious journals such as Nature Biotechnology, Nature Scientific Reports, and BMC Medical Genomics.

In addition to her scientific pursuits, she is also a passionate advocate for translational science and policy, focusing on reducing health disparities in the Black community and restoring health justice. Kaylin performed a preliminary landscape analysis at the Frederick National Laboratory for Cancer Research, assessing R2 HBCU capacity and showcasing their capabilities in cancer research to enhance the understanding of how to improve engagement and authentic partnerships with these institutions. Kaylin’s work has contributed to significant dialogues with leaders in STEM diversity at events such as the UNCF UNITE Conference.

Kaylin is committed to leveraging novel technologies to redefine disease management and democratize scientific access and sustainability, with a vision to pioneer revolutionary medical device technology that transforms global health outcomes.